As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.
As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.
Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.
E9 Exploring the complex impact of Long COVID, this podcast ft. Prof David Cutler from Harvard University, delves into the ongoing health challenges, workforce implications, and the critical need for improved healthcare solutions in the U.S.
Postural Orthostatic Tachycardia Syndrome (POTS) is a condition characterized by an abnormal increase in heart rate upon standing. Symptoms include dizziness, lightheadedness, fatigue, and sometimes fainting. POTS affects blood circulation, leading to inadequate blood flow to the brain and other organs. Read more >
This research conducted interviews via telemedicine of 165 patients with Long COVID over a 2-year time frame.
Researchers are looking at whether medications used to treat or prevent HIV may also alleviate long Covid symptoms.
Danielle Beckham Neuroscientist at the @CNPRCresearch . MS in Biophysics, PhD in Biological Chemistry. With her latest entry to NeuroArt "Unwelcome guest: SARS-Cov-2" - If you like it, please vote!
This research concludes that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection ....
They looked at the pre-delta, delta and omicron eras of infection with SARS-CoV-2 and showed that the risk of Long COVID decreased over the course of the pandemic from 10% to 8% in unvaccinated persons. The results of this trial have been talked about on social media with a lot of disappointment as Paxlovid didn’t
A study on long Covid patients revealed persistent immune activation and potential virus presence in various organs even years after infection. The research utilized imaging techniques to identify immune activation in the brain, spinal cord, lungs, and gut wall. The findings suggest a need for further investigation into treatments targeting leftover virus and immunomodulating therapies....
A news article discusses the shift towards decentralized clinical trials (DCTs) for long COVID treatments, enabling patients to participate from home rather than traveling to clinical sites.....